...
首页> 外文期刊>PDA journal of pharmaceutical science and technology >Usability of the Ranibizumab 0.5 mg Prefilled Syringe: Human Factors Studies to Evaluate Critical Task Completion by Healthcare Professionals
【24h】

Usability of the Ranibizumab 0.5 mg Prefilled Syringe: Human Factors Studies to Evaluate Critical Task Completion by Healthcare Professionals

机译:Ranibizumab的可用性0.5 mg预填充注射器:人类因素研究,以评估医疗保健专业人员的关键任务完成

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: A ranibizumab prefilled syringe (PFS) has been approved by the U.S. Food and Drug Administration. Here we evaluate the use of the ranibizumab PFS for intravitreal injection by assessing whether the PFS enables healthcare providers to successfully prepare and administer an injection without prior training. Design: Simulated-use and actual-use human factors usability studies. Participants: Retina specialists and ophthalmic medical personnel. Methods: In a simulated-use summative usability study, retina specialists (n = 15) and ophthalmic medical personnel (n = 15) prepared the ranibizumab PFS and performed injections into a model eye. In an actual-use formative usability study (ClinicalTrials.gov identifier: NCT02698566), three assistants and three retina specialists prepared the PFS and performed intravitreal injections, respectively, in study eyes of patients with retinal diseases (n = 35). Main Outcome Measures: Twelve tasks specific to the unpacking, preparing, and properly administering the PFS for intravitreal injection were evaluated by a study assessor. Task performances were evaluated for use errors, close calls, and operational difficulties. Post-injection subjective user evaluations were performed to assess ease of use. Results: All participants successfully performed all essential and safety-critical tasks without use error in both the simulated-use and actual-use human factors usability studies. The majority of participants rated the tasks required to use the ranibizumab PFS as “Easy” or “Very Easy.” Conclusions: Both the simulated-use and actual-use usability studies yielded consistent data, showing that healthcare professionals are able to use the ranibizumab PFS by successfully performing all critical tasks involved in preparing and delivering an intravitreal injection. The simulated-use usability testing was sufficiently realistic and representative of real-world use, and was appropriate and preferred over actual-use usability testing for proper evaluation of the product user interface.
机译:目的:通过美国食品和药物管理局批准了Ranibizumab预填充的注射器(PFS)。在这里,我们通过评估PFS是否能够在未经事先培训的情况下成功准备和管理注射来评估RANIBIZUMAB PFS进行玻璃体内注射的使用。设计:模拟使用和实际使用人类因素可用性研究。参与者:视网膜专家和眼科医生。方法:在模拟使用总结可用性研究中,视网膜专家(N = 15)和眼科医生(n = 15)制备了Ranibizumab PFS并进行了注射到模型眼中。在实际使用的形成性可用性研究(ClinicalTrials.gov标识符:NCT02698566)中,三个助理和三个视网膜专家制备了PFS,并分别进行了术治疗视网膜疾病患者的研究眼(n = 35)。主要观察措施:通过研究评估员评估对拆包,制备和适当地施用玻璃体内注射的PFS的12个任务。评估任务性能的使用错误,近呼叫和操作困难。进行注射后主观用户评估以评估易用性。结果:所有参与者在模拟使用和实际使用人类因素可用性研究中成功地在无需使用错误的情况下进行了所有必要和安全关键任务。大多数参与者评分了使用Ranibizumab PFS作为“简单”或“非常容易”所需的任务。结论:模拟使用和实际使用的可用性研究都产生了一致的数据,显示医疗保健专业人员可以通过成功执行制备和提供玻璃体内注射的所有关键任务来使用RANibizumab PFS。模拟使用可用性测试是真实的和代表实际使用的,并且是适当的,并且优先于实际使用的可用性测试,以便对产品用户界面进行适当的评估。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号